Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention

Suzan M. Walters; Kathleen H. Reilly; Alan Neaigus; Sarah Braunstein

doi:10.1186/s12954-017-0166-x

journal article Jun 29, 2017

Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention

Suzan M. Walters Kathleen H. Reilly Alan Neaigus Sarah Braunstein

Harm Reduction Journal Vol. 14 No. 1 · Springer Science and Business Media LLC

View at Publisher Save 10.1186/s12954-017-0166-x

Topics

No keywords indexed for this article. Browse by subject →

References

125

[1]

Centers for Disease Control and Prevention. HIV surveillance report; vol. 27. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2015-vol-27.pdf . Published Nov. 2016. Accessed 5 Jan 2017.

[2]

Lansky A, Finlayson T, Johnson C, et al. Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections. 2014. 10.1371/journal.pone.0097596

[3]

Des Jarlais DC, Feelemyer JP, Modi SN, Arasteh K, Hagan H. Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend. 2012;124(1):95–107. 10.1016/j.drugalcdep.2011.12.020

[4]

Evans MJL, Hahn JA, Page-Shafer MK, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003;80(1):137–46. 10.1093/jurban/jtg137

[5]

Page K, Tsui J, Maher L, et al. Biomedical HIV prevention including pre-exposure prophylaxis and opiate agonist therapy for women who inject drugs: state of research and future directions. J Acquir Immune Defic Syndr. 2015;69 Suppl 2:S169–75. doi: 10.1097/QAI.0000000000000641 . 10.1097/qai.0000000000000641

[6]

Spittal PM, Craib KJ, Wood E, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ. 2002;166(7):894–9.

[7]

Adimora AA, Schoenbach VJ. Contextual factors and the black-white disparity in heterosexual HIV transmission. Epidemiology. 2002;13(6):707–12. 10.1097/00001648-200211000-00016

[8]

Adimora AA, Schoenbach VJ, Bonas DM, Martinson FE, Donaldson KH, Stancil TR. Concurrent sexual partnerships among women in the United States. Epidemiology. 2002;13(3):320–7. 10.1097/00001648-200205000-00013

[9]

Adimora AA, Schoenbach VJ. Social context, sexual networks, and racial disparities in rates of sexually transmitted infections. J Infect Dis. 2005;191 Suppl 1:S115–22. doi: JID32102 [pii]. 10.1086/425280

[10]

Amaro H. Love, sex, and power: considering women's realities in HIV prevention. Am Psychol. 1995;50(6):437. 10.1037/0003-066x.50.6.437

[11]

The Problem With the Phrase Women and Minorities: Intersectionality—an Important Theoretical Framework for Public Health

Lisa Bowleg

American Journal of Public Health 2012 10.2105/ajph.2012.300750

[12]

Fullilove MT, Fullilove III RE, Haynes K, Gross S. Black women and AIDS prevention: a view towards understanding the gender rules. J Sex Res. 1990;27(1):47–64. 10.1080/00224499009551541

[13]

Harawa N, Adimora A. Incarceration, African Americans and HIV: advancing a research agenda. J Natl Med Assoc. 2008;100(1):57–62. 10.1016/s0027-9684(15)31175-5

[14]

Wingood GM Scd, DiClemente RJ. Application of the theory of gender and power to examine HIV-related exposures, risk factors, and effective interventions for women. Health Educ Behav. 2000;27(5):539–65. 10.1177/109019810002700502

[15]

Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis

Stefan Baral, Chris Beyrer, Kathryn Muessig et al.

The Lancet Infectious Diseases 2012 10.1016/s1473-3099(12)70066-x

[16]

Pulerwitz J, Amaro H, Jong WD, Gortmaker SL, Rudd R. Relationship power, condom use and HIV risk among women in the USA. AIDS Care. 2002;14(6):789–800. 10.1080/0954012021000031868

[17]

Wyatt GE, Carmona JV, Loeb TB, Guthrie D, Chin D, Gordon G. Factors affecting HIV contraceptive decision-making among women. Sex Roles. 2000;42(7-8):495–521. 10.1023/a:1007091121084

[18]

Bennett G, Velleman R, Barter G, Bradbury C. Gender differences in sharing injecting equipment by drug users in England. AIDS Care. 2000;12(1):77–87. 10.1080/09540120047495

[19]

Frajzyngier V, Neaigus A, Gyarmathy VA, Miller M, Friedman SR. Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend. 2007;89(2):145–52. 10.1016/j.drugalcdep.2006.12.021

[20]

Neaigus A, Reilly KH, Jenness SM, Hagan H, Wendel T, Gelpi-Acosta C. Dual HIV risk: receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City. AIDS Behav. 2013;17(7):2501–9. 10.1007/s10461-013-0496-y

[21]

Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health. 2003;80(3):iii7–iii14.

[22]

Centers for Disease Control and Prevention. HIV and injection drug use. Retrieved Jan. 30, 2017 ( https://www.cdc.gov/hiv/pdf/risk/cdc-hiv-idu-fact-sheet.pdf )

[23]

Jenness SM, Neaigus A, Hagan H, Murrill CS, Wendel T. Heterosexual HIV and sexual partnerships between injection drug users and noninjection drug users. AIDS Patient Care STDS. 2010;24(3):175–81. 10.1089/apc.2009.0227

[24]

Jenness SM, Kobrak P, Wendel T, Neaigus A, Murrill CS, Hagan H. Patterns of exchange sex and HIV infection in high-risk heterosexual men and women. J Urban Health. 2011;88(2):329–41. 10.1007/s11524-010-9534-5

[25]

Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357(9266):1397–401. doi: 10.1016/S0140-6736(00)04562-1 . 10.1016/s0140-6736(00)04562-1

[26]

Rondinelli AJ, Ouellet LJ, Strathdee SA, et al. Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug Alcohol Depend. 2009;104(1–2):167–74. doi: 10.1016/j.drugalcdep.2009.05.013 . 10.1016/j.drugalcdep.2009.05.013

[27]

Astemborski J, Vlahov D, Warren D, Solomon L, Nelson KE. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health. 1994;84(3):382–7. 10.2105/ajph.84.3.382

[28]

Weber MAE, Boivin J, Blais L, Haley N, Roy É. HIV risk profile and prostitution among female street youths. J Urban Health. 2002;79(4):525–35. 10.1093/jurban/79.4.525

[29]

Sexual risk behavior among heterosexual intravenous drug users

Diane K. Lewis, John K. Watters

AIDS 1991 10.1097/00002030-199101000-00011

[30]

Inciardi JA, Surratt HL, Kurtz SP. HIV, HBV, and HCV infections among drug-involved, inner-city, street sex workers in Miami. Florida AIDS and Behavior. 2006;10(2):139–47. 10.1007/s10461-005-9049-3

[31]

Shannon K, Kerr T, Allinott S, Chettiar J, Shoveller J, Tyndall MW. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med. 2008;66(4):911–21. 10.1016/j.socscimed.2007.11.008

[32]

Shannon K, Strathdee SA, Goldenberg SM, et al. Global epidemiology of HIV among female sex workers: influence of structural determinants. The Lancet. 2015;385(9962):55–71. 10.1016/s0140-6736(14)60931-4

[33]

Strathdee SA, Philbin MM, Semple SJ, et al. Correlates of injection drug use among female sex workers in two Mexico–US border cities. Drug Alcohol Depend. 2008;92(1):132–40. 10.1016/j.drugalcdep.2007.07.001

[34]

Abel G, Fitzgerald L, Healy C, Taylor A, editors. Taking the crime out of sex work: New Zealand sex workers’ fight for decriminalization. Great Britian: The Policy Press; 2010.

[35]

Gall G. Sex worker union organising. Ontario: Palgrave Macmillan; 2006. 10.1057/9780230502482

[36]

Hoefinger H. ‘PROFESSIONAL GIRLFRIENDS’ an ethnography of sexuality, solidarity and subculture in Cambodia. Cult Stud. 2011;25(2):244–66. 10.1080/09502386.2011.535990

[37]

Jenness V. Making it work: the prostitutes rights movement in perspective. New York: Aldine De Gruyter; 1993.

[38]

Majic S. Sex work politics: from protest to service provision. Pennsylvania: University of Pennsylvania Press; 2013. 10.9783/9780812209020

[39]

Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61(5):1026–44. 10.1016/j.socscimed.2004.12.024

[40]

Cooper H, Friedman SR, Tempalski B, Friedman R, Keem M. Racial/ethnic disparities in injection drug use in large US metropolitan areas. Ann Epidemiol. 2005;15(5):326–34. 10.1016/j.annepidem.2004.10.008

[41]

Des Jarlais DC, McCarty D, Vega WA, Bramson H. HIV infection among people who inject drugs: the challenge of racial/ethnic disparities. Am Psychol. 2013;68(4):274. 10.1037/a0032745

[42]

Estrada AL. Health disparities among African-American and Hispanic drug injectors–HIV, AIDS, hepatitis B virus and hepatitis C virus: a review. AIDS. 2005;19:S47–52. 10.1097/01.aids.0000192070.95819.7c

[43]

Song JY, Safaeian M, Strathdee SA, Vlahov D, Celentano DD. The prevalence of homelessness among injection drug users with and without HIV infection. J Urban Health. 2000;77(4):678–87. 10.1007/bf02344031

[44]

Magura S, Nwakeze PC, Rosenblum A, Joseph H. Substance misuse and related infectious diseases in a soup kitchen population. Subst Use Misuse. 2000;35(4):551–83. 10.3109/10826080009147472

[45]

Schechter MT, Strathdee SA, Cornelisse PG, Currie S, Patrick DM, Rekart ML. Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS. 1999;13(6):F45–51. 10.1097/00002030-199904160-00002

[46]

Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61(5):1026–44. doi: 10.1016/j.socscimed.2004.12.024 . 10.1016/j.socscimed.2004.12.024

[47]

Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep. 2002;117 Suppl 1:S135–45.

[48]

Stein MD, Hanna L, Natarajan R, et al. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. J Subst Abuse Treat. 2000;18(4):359–63. 10.1016/s0740-5472(99)00070-7

[49]

Booth RE, Watters JK, Chitwood DD. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health. 1993;83(8):1144–8. 10.2105/ajph.83.8.1144

[50]

Khan MR, Berger A, Hemberg J, O’Neill A, Dyer TP, Smyrk K. Non-injection and injection drug use and STI/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users. AIDS Behav. 2013;17(3):1185–94. 10.1007/s10461-012-0276-0

Showing 50 of 125 references

Cited By

115

The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review

Colleen B. Mistler, Michael M. Copenhaver · 2020

AIDS and Behavior

Metrics

115

Citations

125

References

Details

Published: Jun 29, 2017
Vol/Issue: 14(1)

Authors

Cite This Article

Suzan M. Walters, Kathleen H. Reilly, Alan Neaigus, et al. (2017). Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention. Harm Reduction Journal, 14(1). https://doi.org/10.1186/s12954-017-0166-x

Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention

You May Also Like